(Q34537374)

2 August 2017

title

Clinical validation of an autoantibody test for lung cancer (English)

1 reference

2 August 2017

1 reference

1 reference

1

1 reference

2 August 2017

C J Chapman

2

1 reference

2 August 2017

S Holdenrieder

3

1 reference

2 August 2017

A Murray

4

1 reference

2 August 2017

C Robertson

5

1 reference

2 August 2017

W C Wood

6

1 reference

2 August 2017

P Maddison

7

1 reference

2 August 2017

G Healey

8

1 reference

2 August 2017

G H Fairley

9

1 reference

2 August 2017

A C Barnes

10

1 reference

2 August 2017

J F R Robertson

11

1 reference

2 August 2017

publication date

30 July 2010

1 reference

2 August 2017

1 reference

2 August 2017

volume

22

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

383-389

1 reference

Technical validation of an autoantibody test for lung cancer

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Projected cancer risks from computed tomographic scans performed in the United States in 2007

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Profiling tumor-associated antibodies for early detection of non-small cell lung cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

NY-ESO-1: review of an immunogenic tumor antigen

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Diagnostic performance of digital versus film mammography for breast-cancer screening

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

CT screening for lung cancer: five-year prospective experience

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

p53 autoantibodies predict subsequent development of cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

SeroGRID: an improved method for the rapid selection of antigens with disease related immunogenicity.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Innovative molecular and imaging approaches for the detection of lung cancer and its precursor lesions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Identification and characterization of a novel cancer/testis antigen gene CAGE.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Mass screening for lung cancer with mobile spiral computed tomography scanner

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Cancer antigens: immune recognition of self and altered self

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Failure of CA19-9 to detect asymptomatic colorectal carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Early Lung Cancer Action Project: overall design and findings from baseline screening.

7 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Early lung cancer action project: initial findings on repeat screenings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Lung cancer screening: a different paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Autoantibodies in lung cancer: possibilities for early detection and subsequent cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Circulating anti-p53 antibodies in lung cancer and relationship to histology and smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3030465

Assessment of four monoclonal antibodies as serum markers in breast cancer

27 October 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

Prospective assessment of the role of five tumour markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ361

T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease

21 January 2018

1 reference

12 December 2020

A risk model for prediction of lung cancer

1 reference

12 December 2020

Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smoking

1 reference

12 December 2020

Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project

1 reference

12 December 2020

Autoantibodies in breast cancer: their use as an aid to early diagnosis

1 reference

12 December 2020

Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer

1 reference

12 December 2020

Role of Plasma Carcinoembryonic Antigen in Diagnosis of Gastrointestinal, Mammary, and Bronchial Carcinoma

1 reference

12 December 2020

Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients

1 reference

12 December 2020

Autoantibody biomarker opens a new gateway for cancer diagnosis

1 reference

12 December 2020

Identifiers

DOI

10.1093/ANNONC/MDQ361

1 reference

2 August 2017

1 reference

2 August 2017

1 reference